Livedoid vasculitis
A Livedoid vasculitis egy krónikus bőrbetegség, amely elsősorban fiatal és középkorú nőknél fordul elő. Jellemzőinek leírására használt egyik mozaikszó a "Fájdalmas, purpurikus fekélyek az alsó végtagok retikuláris mintájával" (LILA). Számos betegséggel jár, beleértve a krónikus vénás hipertóniát és a varikózisokat.
☆ A 2022-es németországi Stiftung Warentest eredményei szerint a fogyasztók elégedettsége a ModelDermmel csak valamivel volt alacsonyabb, mint a fizetős távorvoslási konzultációkkal.
Fájdalom kísérheti.
References
A Livedoid vasculopathy egy ritka bőrbetegség, amelyet fájdalmas fekélyek jellemeznek, amelyek folyamatosan visszatérnek az alsó lábakon.
Livedoid vasculopathy (LV) is a rare thrombotic vasculopathy of the dermis characterized by painful, relapsing ulcers over the lower extremities. Diagnosis is challenging due to the overlap in clinical appearance and nomenclature with other skin disorders. Treatment selection is complicated by poor understanding of the pathogenesis of LV and lack of robust clinical trials evaluating therapy efficacy. The terminology and pathophysiology of LV are reviewed here, along with its epidemiology, clinical and histologic features, and treatment options. A diagnostic pathway is suggested to guide providers in evaluating for comorbidities, referring to appropriate specialists, and choosing from the available classes of therapy.
Livedoid vasculopathy (LV) is a rare thrombotic vasculopathy of the dermis characterized by painful, relapsing ulcers over the lower extremities. Diagnosis is challenging due to the overlap in clinical appearance and nomenclature with other skin disorders. Treatment selection is complicated by poor understanding of the pathogenesis of LV and lack of robust clinical trials evaluating therapy efficacy. The terminology and pathophysiology of LV are reviewed here, along with its epidemiology, clinical and histologic features, and treatment options. A diagnostic pathway is suggested to guide providers in evaluating for comorbidities, referring to appropriate specialists, and choosing from the available classes of therapy.
A Livedoid vasculopathy egy ritka bőrbetegség, amely visszatérő fekélyeket okoz az alsó lábakon, sápadt hegeket hagyva maga után, az atrophie blanche néven ismert. Bár a pontos ok még mindig nem tisztázott, úgy vélik, hogy a fokozott véralvadás (hypercoagulability) a fő tényező, a gyulladás pedig másodlagos szerepet játszik. A véralvadást elősegítő tényezők a következők: - deficiencies in proteins C and S, genetic mutations like factor V Leiden, antithrombin III deficiency, prothrombin gene mutations, high levels of homocysteine. A biopsziák során az állapot vérrögöket mutat az erekben, az érfalak megvastagodását és hegesedést. A kezelés sokrétű megközelítést foglal magában, amely a vérrögképződés megelőzésére összpontosít olyan gyógyszerekkel, mint a vérlemezke-ellenes szerek, vérhígítók és fibrinolitikus terápia. Különféle gyógyszerek alkalmazhatók erre a bőrbetegségre - colchicine and hydroxychloroquine, vasodilators, immunosuppressants.
Livedoid vasculopathy is a rare skin condition that causes recurring ulcers on the lower legs, leaving behind pale scars known as atrophie blanche. While the exact cause is still unclear, it's believed that increased blood clotting (hypercoagulability) is the main factor, with inflammation playing a secondary role. Factors contributing to clotting include as follows - deficiencies in proteins C and S, genetic mutations like factor V Leiden, antithrombin III deficiency, prothrombin gene mutations, high levels of homocysteine. In biopsies, the condition shows blood clots inside vessels, thickening of vessel walls, and scarring. Treatment involves a multi-pronged approach focusing on preventing blood clots with medications like anti-platelet drugs, blood thinners, and fibrinolytic therapy. Various drugs can be used for this skin condition - colchicine and hydroxychloroquine, vasodilators, immunosuppressants.
Livedoid vasculopathy is a rare skin condition that causes recurring ulcers on the lower legs, leaving behind pale scars known as atrophie blanche. While the exact cause is still unclear, it's believed that increased blood clotting (hypercoagulability) is the main factor, with inflammation playing a secondary role. Factors contributing to clotting include as follows - deficiencies in proteins C and S, genetic mutations like factor V Leiden, antithrombin III deficiency, prothrombin gene mutations, high levels of homocysteine. In biopsies, the condition shows blood clots inside vessels, thickening of vessel walls, and scarring. Treatment involves a multi-pronged approach focusing on preventing blood clots with medications like anti-platelet drugs, blood thinners, and fibrinolytic therapy. Various drugs can be used for this skin condition - colchicine and hydroxychloroquine, vasodilators, immunosuppressants.
A Livedoid vasculopathy egy ritka állapot, amikor mindkét lábon elváltozások fordulnak elő. Úgy gondolják, hogy az apró erekben a vérrögök képződését a megnövekedett véralvadás és a csökkent vérröglebomlás, valamint az érfal károsodása okozza. Gyakrabban fordul elő nőknél, különösen 15 és 50 éves kor között. A dohányzásról való leszokás, a sebek ápolása és olyan gyógyszerek alkalmazása, mint a vérhígítók és a thrombocyta-aggregációt gátló szerek, hatékonyak voltak.
Livedoid vasculopathy is a rare vasculopathy that is typically characterized by bilateral lower limb lesions. Increased thrombotic activity and decreased fibrinolytic activity along with endothelial damage are believed to be the cause of thrombus formation in the capillary vasculature. It is 3 times more common in females than in males, especially in patients between the ages of 15 to 50 years. There is no definite first-line treatment, but general measures like smoking cessation, wound care, and pharmacological measures like anticoagulants and antiplatelets have shown good results.
Livedoid vasculopathy is a rare vasculopathy that is typically characterized by bilateral lower limb lesions. Increased thrombotic activity and decreased fibrinolytic activity along with endothelial damage are believed to be the cause of thrombus formation in the capillary vasculature. It is 3 times more common in females than in males, especially in patients between the ages of 15 to 50 years. There is no definite first-line treatment, but general measures like smoking cessation, wound care, and pharmacological measures like anticoagulants and antiplatelets have shown good results.
